- Home
- XNCR vs GMRE Comparison
XNCR vs GMRE Comparison
Compare XNCR & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- GMRE
- Stock Information
- Founded
- XNCR 1997
- GMRE 2011
- Country
- XNCR United States
- GMRE United States
- Employees
- XNCR N/A
- GMRE N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- GMRE Real Estate Investment Trusts
- Sector
- XNCR Health Care
- GMRE Real Estate
- Exchange
- XNCR Nasdaq
- GMRE Nasdaq
- Market Cap
- XNCR 565.1M
- GMRE 485.5M
- IPO Year
- XNCR 2013
- GMRE N/A
- Fundamental
- Price
- XNCR $8.44
- GMRE $7.05
- Analyst Decision
- XNCR Buy
- GMRE Buy
- Analyst Count
- XNCR 7
- GMRE 3
- Target Price
- XNCR $27.50
- GMRE $10.38
- AVG Volume (30 Days)
- XNCR 777.2K
- GMRE 869.6K
- Earning Date
- XNCR 08-04-2025
- GMRE 08-05-2025
- Dividend Yield
- XNCR N/A
- GMRE 11.86%
- EPS Growth
- XNCR N/A
- GMRE N/A
- EPS
- XNCR N/A
- GMRE 0.03
- Revenue
- XNCR $127,228,000.00
- GMRE $138,220,000.00
- Revenue This Year
- XNCR N/A
- GMRE $4.64
- Revenue Next Year
- XNCR $28.84
- GMRE $3.78
- P/E Ratio
- XNCR N/A
- GMRE $221.19
- Revenue Growth
- XNCR N/A
- GMRE N/A
- 52 Week Low
- XNCR $7.16
- GMRE $6.06
- 52 Week High
- XNCR $27.24
- GMRE $10.46
- Technical
- Relative Strength Index (RSI)
- XNCR 47.36
- GMRE 63.29
- Support Level
- XNCR $7.93
- GMRE $7.01
- Resistance Level
- XNCR $9.48
- GMRE $7.29
- Average True Range (ATR)
- XNCR 0.53
- GMRE 0.21
- MACD
- XNCR 0.06
- GMRE 0.04
- Stochastic Oscillator
- XNCR 43.29
- GMRE 85.48
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.